BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35838503)

  • 21. Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
    Pruthi DK; Miller G; Ankerst DP; Neumair M; Capitanio U; Correa AF; Lane BR; Roussel E; McGregor TB; Derweesh IH; Cordeiro M; Pierorazio PM; Calvo C; Bi H; Noyes SL; Meagher M; Kutikov A; Uzzo RG; Van Poppel H; Larcher A; Montorsi F; Kattan MW; Kaushik D; Liss MA
    J Urol; 2023 Nov; 210(5):750-762. PubMed ID: 37579345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
    Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
    Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
    Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
    Li L; Shi L; Zhang J; Fan Y; Li Q
    Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
    Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
    Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?
    Asselin C; Finelli A; Breau RH; Mallick R; Kapoor A; Rendon RA; Tanguay S; Pouliot F; Fairey A; Lavallée LT; Bladou F; Kawakami J; So AI; Richard PO
    Urol Oncol; 2020 Oct; 38(10):798.e9-798.e16. PubMed ID: 32693974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).
    Schiavina R; Mari A; Bianchi L; Amparore D; Antonelli A; Artibani W; Brunocilla E; Capitanio U; Fiori C; Di Maida F; Gontero P; Larcher A; Li Marzi V; Longo N; Marra G; Montanari E; Porpiglia F; Roscigno M; Simeone C; Siracusano S; Tellini R; Terrone C; Villari D; Ficarra V; Carini M; Minervini A;
    Eur J Surg Oncol; 2020 Jul; 46(7):1353-1359. PubMed ID: 32007380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
    Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
    Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
    Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Preoperative Predictive Factors for Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma.
    Fukui S; Miyake M; Iida K; Onishi K; Hori S; Morizawa Y; Kagebayashi Y; Fujimoto K
    Diagnostics (Basel); 2019 Jul; 9(3):. PubMed ID: 31311108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a.
    Liu H; Wang Z; Peng E; Chen Z; Tang K; Xia D
    Front Oncol; 2021; 11():679536. PubMed ID: 34136403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
    Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
    BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with pathological tumor stage and T3a upstage in clinical T1-2 renal cell carcinoma.
    Kalfazade N; Özlü DN; Şam E; Akkaş F; Gürbüz N
    Prog Urol; 2023 Mar; 33(3):135-144. PubMed ID: 36604246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic upstaging after laparoscopic radical nephrectomy.
    Goel MC; Mohammadi Y; Sethi AS; Brown JA; Sundaram CP
    J Endourol; 2008 Oct; 22(10):2257-61. PubMed ID: 18937590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
    Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
    Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robotic surgery does not affect upstaging of T1 renal masses.
    Davaro F; Roberts J; May A; McFerrin C; Siddiqui S; Hamilton Z
    J Robot Surg; 2020 Jun; 14(3):447-454. PubMed ID: 31456083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.